Back
Protagonist Therapeutics Vs. Johnson & Johnson Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
47.52
Seasonality Move:
13.55%
Sell
50
JNJ
Johnson & Johnson
Last Price:
164.35
Seasonality Move:
3.21%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $164.10. The Score for JNJ is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $164.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 65.65 | Buy |
| Chaikin Money Flow: | 126936 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.19 - 46.41) | Buy |
| Bollinger Bands (100): | (33.39 - 44.11) | Buy |
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 59.22 | Buy |
| Chaikin Money Flow: | 3226835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.43 - 164.93) | Buy |
| Bollinger Bands (100): | (148.78 - 163.9) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.87 | Buy |
| 20-day SMA: | 45.2 | Buy |
| 50-day SMA: | 43.19 | Buy |
| 200-day SMA: | 33.03 | Buy |
| 8-day EMA: | 45.46 | Buy |
| 20-day EMA: | 44.91 | Buy |
| 50-day EMA: | 42.95 | Buy |
| 200-day EMA: | 34.35 | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.98 | Buy |
| 20-day SMA: | 161.9 | Buy |
| 50-day SMA: | 162.56 | Buy |
| 200-day SMA: | 156.02 | Buy |
| 8-day EMA: | 161.7 | Buy |
| 20-day EMA: | 161.95 | Buy |
| 50-day EMA: | 161.19 | Buy |
| 200-day EMA: | 157.46 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.77 per share.
Protagonist Therapeutics Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Johnson & Johnson Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||